Teriflunomide and Time to Clinical Multiple Sclerosis in Radiologically Isolated Syndrome

This randomized clinical trial investigates the efficacy of the disease-modifying treatment, teriflunomide, in extending the time to a first clinical event in patients with preclinical multiple sclerosis.
Source: JAMA Neurology - Category: Neurology Source Type: research